Assignee
ADOCIA
FR·33 granted patents·50 pending applications·60 citations·filing 2008–2024
Top patents by PatentIndex Score
83 records- 0193US10646551B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2019·Granted May 12, 2020·3 cites·26 claims
- 0293US9457089B2Highly concentrated aqueous protein solution with reduced viscosityADOCIA·Filed 2013·Granted Oct 4, 2016·13 cites·21 claims
- 0387US9492467B2Rapid-acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2014·Granted Nov 15, 2016·3 cites·32 claims
- 0485US9795678B2Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compoundADOCIA·Filed 2015·Granted Oct 24, 2017·3 cites·27 claims
- 0585US9278131B2Process for lowering the viscosity of highly concentrated protein solutionsADOCIA·Filed 2013·Granted Mar 8, 2016·9 cites·30 claims
- 0684US11065305B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2020·Granted Jul 20, 2021·1 cites·19 claims
- 0784US10881716B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2020·Granted Jan 5, 2021·1 cites·7 claims
- 0881US10610572B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2018·Granted Apr 7, 2020·2 cites·20 claims
- 0981US8367640B2Complex consisted of a polysaccharide and an HBPADOCIA·Filed 2009·Granted Feb 5, 2013·3 cites·12 claims
- 1080US10583175B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2017·Granted Mar 10, 2020·2 cites·33 claims
- 1180US9700599B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2013·Granted Jul 11, 2017·3 cites·14 claims
- 1279US10485851B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 26, 2019·3 cites·16 claims
- 1378US11191812B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Dec 7, 2021·1 cites·17 claims
- 1478US10463717B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 5, 2019·3 cites·12 claims
- 1578US10383918B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acidADOCIA·Filed 2017·Granted Aug 20, 2019·3 cites·15 claims
- 1678US2025099551A1Thermostable formulation of a21g human insulinADOCIA·Filed 2024·Application pending·0 cites
- 1776US11324808B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2020·Granted May 10, 2022·0 cites·22 claims
- 1876US10548952B2Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Feb 4, 2020·2 cites·36 claims
- 1976US10383920B2Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Aug 20, 2019·2 cites·18 claims
- 2075US11633460B2Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Granted Apr 25, 2023·2 cites·15 claims
- 2175US2025090638A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2024·Application pending·0 cites
- 2270US10792335B2Rapid-acting insulin composition comprising a substituted citrateADOCIA·Filed 2016·Granted Oct 6, 2020·1 cites·21 claims
- 2369US2019216931A1Injectable ph 7 solution comprising at least one basal insulin having a pi from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 2467US2024115663A1Compositions comprising at least an insulin and an amylin receptor agonist for treating diabetes, in a patient/person having a bmi of more than 28 kg/m² and/or an hba1c of more than 7.6%ADOCIA·Filed 2023·Application pending·0 cites
- 2565US11707507B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acidADOCIA·Filed 2019·Granted Jul 25, 2023·0 cites·1 claims
- 2664US12186373B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2021·Granted Jan 7, 2025·0 cites·12 claims
- 2764US2011027363A1Nouvelle forme d'administration de proteines osteogeniquesADOCIA·Filed 2009·Application pending·0 cites
- 2864US2021315977A1Thermostable formulation of a21g human insulinADOCIA·Filed 2019·Application pending·0 cites
- 2964US2026027047A1Hydrogels for cell therapyADOCIA·Filed 2023·Application pending·0 cites
- 3063US2018311316A1Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5ADOCIA·Filed 2018·Application pending·0 cites
- 3162US2015314003A2Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2014·Application pending·0 cites
- 3262US2022409523A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 3361US10449256B2Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2018·Granted Oct 22, 2019·0 cites·10 claims
- 3461US2014235536A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2014·Application pending·0 cites
- 3561US2021205417A1Ph 7 injectable solution comprising at least one basal insulin of which the pi is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresolADOCIA·Filed 2021·Application pending·0 cites
- 3660US2009291114A1Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic supportADOCIA·Filed 2009·Application pending·0 cites
- 3760US2021386830A1Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 3859US11883496B2Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2020·Granted Jan 30, 2024·0 cites·24 claims
- 3959US2020179489A1Injectable solution at ph 7 comprising at least one basal insulin which pi is from 5.8 to 8.5 and a co-polyamino-acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresolADOCIA·Filed 2018·Application pending·0 cites
- 4058US12421327B2Hydrogels for cell therapyADOCIA·Filed 2022·Granted Sep 23, 2025·0 cites·18 claims
- 4158US2018236085A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 4258US2009291113A1Osteogenic composition comprising a growth factor, a soluble cation salt and organic supportADOCIA·Filed 2009·Application pending·0 cites
- 4358US2017143835A1Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide unitsADOCIA·Filed 2017·Application pending·0 cites
- 4458US2013231281A1Rapid acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2012·Application pending·0 cites
- 4557US12544349B1Compositions comprising pemvidutide and an acylated amino acidADOCIA·Filed 2024·Granted Feb 10, 2026·0 cites·30 claims
- 4657US2010137456A1Polysaccharides functionalized by tryptophan derivativesADOCIA·Filed 2009·Application pending·0 cites
- 4757US2013245246A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2013·Application pending·0 cites
- 4857US2019275110A1Compositions in the form of an injectale aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Application pending·0 cites
- 4957US2023210957A1Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial actionADOCIA·Filed 2021·Application pending·0 cites
- 5056US11173109B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2018·Granted Nov 16, 2021·0 cites·18 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ADOCIA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →